Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...

Clover Leaf Capital Corp. (NASDAQ: CLOEU) has closed its previously announced initial public offering of some 13,831,230 units at $10 per unit</ Jelena Martinovic Watch Planet 13's CEO & Matt ...

UBS has recently initiated Clover Health Investments Corp (CLOV) stock to Neutral rating, as announced on October 7, 2024, according to Finviz. Earlier, on February 2, 2022, Cowen had raised the stock ...

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping ...

David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. | Clover ...

Clover Health is an insurance company that offers a variety of Medicare Advantage plans. Read on to learn where Clover Health where plans are available in the U.S., as well as details about the ...

Short interest in Clover Leaf Capital Corp (OTC:CLOE) decreased during the last reporting period, falling from 3.22K to 2.73K. This put 0.29% of the company's publicly available shares short.

Oct. 15, 2024 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV ... low specialist and prescription drug copays, enhanced OTC and dental allowances, and a rewards program with the potential ...

“We are proud to reaffirm our commitment to New Jersey by maintaining our affordable benefit-rich PPO plans for 2025,” said Jamie Reynoso, Clover’s CEO of Medicare Advantage. “At a time when many ...

Register to read this story and more for free. Signing up for an account helps us improve your browsing experience.